Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 6, 2022
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
[ Fri, May 06th 2022
] - WOPRAI
Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $18 on, May 6th, 2022
Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $27 to $18 on, May 6th, 2022.
Tejas has made no other calls on ADPT in the last 4 months.
There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, 0 agree with Tejas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tejas
- Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, February 16th, 2022
